Population-wide Impact of Long-term Use of Aspirin and the Risk for Cancer.

Aspirin Use and Reduced Risk of Pancreatic Cancer. Cancer Epidemiol Biomarkers Prev (2016) 1.12

Molecular pathological epidemiology: new developing frontiers of big data science to study etiologies and pathogenesis. J Gastroenterol (2016) 0.86

Regular Aspirin Use Associates With Lower Risk of Colorectal Cancers With Low Numbers of Tumor-Infiltrating Lymphocytes. Gastroenterology (2016) 0.81

Higher rate of microscopic hematuria in elderly patients who take regular doses of aspirin: Result from AHAP Study. Caspian J Intern Med (2016) 0.75

Aspirin and Cancer Risk-Reply. JAMA Oncol (2016) 0.75

Predicting the presence of colon cancer in members of a health maintenance organisation by evaluating analytes from standard laboratory records. Br J Cancer (2017) 0.75

Long term aspirin may reduce overall cancer risk. BMJ (2016) 0.75

Therapeutic dosages of aspirin counteract the IL-6 induced pro-tumorigenic effects by slowing down the ribosome biogenesis rate. Oncotarget (2016) 0.75

Aspirin use and the incidence of breast, colon, ovarian, and pancreatic cancers in elderly women in the Iowa Women's Health Study. Cancer Causes Control (2016) 0.75

Aspirin and Cancer Risk. JAMA Oncol (2016) 0.75

Aspirin and Cancer Risk. JAMA Oncol (2016) 0.75

Aspirin and Cancer Risk. JAMA Oncol (2016) 0.75

ADAM17 in tumor associated leukocytes regulates inflammatory mediators and promotes mammary tumor formation. Genes Cancer (2016) 0.75

Effect of low-dose aspirin use on survival of patients with gastrointestinal malignancies; an observational study. Br J Cancer (2017) 0.75

Aspirin and Cancer Risk. JAMA Oncol (2016) 0.75

Individualised benefit-harm balance of aspirin as primary prevention measure - a good proof-of-concept, but could have been better…. BMC Med (2016) 0.75

Regular and low-dose aspirin, other non-steroidal anti-inflammatory medications and prospective risk of HER2-defined breast cancer: the California Teachers Study. Breast Cancer Res (2017) 0.75

Aspirin Use and Colorectal Cancer Survival According to Tumor CD274 (Programmed Cell Death 1 Ligand 1) Expression Status. J Clin Oncol (2017) 0.75

Exclusive and Combined Use of Statins and Aspirin and the Risk of Pancreatic Cancer: a Case-Control Study. Sci Rep (2017) 0.75

Appropriateness of antiplatelet therapy for primary and secondary cardio- and cerebrovascular prevention in acutely hospitalized older people. Br J Clin Pharmacol (2017) 0.75

Targeting Platelets for the Treatment of Cancer. Cancers (Basel) (2017) 0.75

Triptolide-assisted phosphorylation of p53 suppresses inflammation-induced NF-κB survival pathways in cancer cells. Mol Cell Biol (2017) 0.75

Screening and Preventive Strategies in Esophagogastric Cancer. Surg Oncol Clin N Am (2017) 0.75

Aspirin Prevention of Colorectal Cancer: Focus on NF-κB Signalling and the Nucleolus. Biomedicines (2017) 0.75

Integrated transcriptomic analysis of distance-related field cancerization in rectal cancer patients. Oncotarget (2017) 0.75

Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer (2010) 13.27

Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. Lancet (2010) 13.13

Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet (2010) 11.00

Aspirin and the risk of colorectal cancer in relation to the expression of COX-2. N Engl J Med (2007) 9.04

Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med (2013) 7.72

Aspirin use and survival after diagnosis of colorectal cancer. JAMA (2009) 6.93

Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials. Lancet (2012) 5.81

Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann Intern Med (1994) 5.42

Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials. Lancet (2012) 4.85

Aspirin intake and survival after breast cancer. J Clin Oncol (2010) 4.50

Contribution of platelets to tumour metastasis. Nat Rev Cancer (2011) 4.16

Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer. JAMA (2005) 3.88

Estimates of benefits and harms of prophylactic use of aspirin in the general population. Ann Oncol (2014) 3.73

A prospective study of aspirin use and primary prevention of cardiovascular disease in women. JAMA (1991) 3.67

Association of aspirin and NSAID use with risk of colorectal cancer according to genetic variants. JAMA (2015) 3.62

Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials. Lancet Oncol (2012) 3.37

A large cohort study of long-term daily use of adult-strength aspirin and cancer incidence. J Natl Cancer Inst (2007) 2.95

The role of aspirin in cancer prevention. Nat Rev Clin Oncol (2012) 2.94

Daily aspirin use and prostate cancer-specific mortality in a large cohort of men with nonmetastatic prostate cancer. J Clin Oncol (2014) 2.87

Coffee consumption and prostate cancer risk and progression in the Health Professionals Follow-up Study. J Natl Cancer Inst (2011) 2.85

Aspirin dose and duration of use and risk of colorectal cancer in men. Gastroenterology (2007) 2.73

The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. J Neurol Neurosurg Psychiatry (1991) 2.49

Aspirin and cancer risk: a quantitative review to 2011. Ann Oncol (2012) 2.45

Alternate-day, low-dose aspirin and cancer risk: long-term observational follow-up of a randomized trial. Ann Intern Med (2013) 2.33

Aspirin use and risk of colorectal cancer according to BRAF mutation status. JAMA (2013) 2.26

Aspirin in the chemoprevention of colorectal neoplasia: an overview. Cancer Prev Res (Phila) (2011) 2.03

Use of aspirin, other nonsteroidal anti-inflammatory drugs, and acetaminophen and postmenopausal breast cancer incidence. J Clin Oncol (2012) 1.85

Routine aspirin or nonsteroidal anti-inflammatory drugs for the primary prevention of colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2007) 1.71

Non-steroidal anti-inflammatory drugs and risk of gastric and oesophageal adenocarcinomas: results from a cohort study and a meta-analysis. Br J Cancer (2009) 1.61

Non-steroidal anti-inflammatory drugs and colorectal cancer risk in a large, prospective cohort. Am J Gastroenterol (2011) 1.34

Aspirin and colorectal cancer: the promise of precision chemoprevention. Nat Rev Cancer (2016) 1.14

Aspirin for prophylactic use in the primary prevention of cardiovascular disease and cancer: a systematic review and overview of reviews. Health Technol Assess (2013) 1.11

Aspirin use and the risk of gastric cancer: a meta-analysis. Dig Dis Sci (2009) 1.08

Aspirin and lung cancer risk in a cohort study of women: dosage, duration and latency. Br J Cancer (2007) 1.04

Relationship between aspirin use after diagnosis of colorectal cancer and patient survival: a meta-analysis of observational studies. Br J Cancer (2014) 1.01

Aspirin use after a prostate cancer diagnosis and cancer survival in a prospective cohort. Cancer Prev Res (Phila) (2012) 0.98

Molecular pathways: aspirin and Wnt signaling-a molecularly targeted approach to cancer prevention and treatment. Clin Cancer Res (2014) 0.96

Where Do We Stand With Aspirin for the Prevention of Colorectal Cancer? The USPSTF Recommendations. Gastroenterology (2015) 0.88

Association of Physical Activity by Type and Intensity With Digestive System Cancer Risk. JAMA Oncol (2016) 0.79